Healthcare stocks were declining premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1.5% lower and the iShares Biotechnology ETF (IBB) down 0.9%.

Moderna (MRNA) shares were up 1.5% after the company swung to Q3 earnings on higher revenue, and raised its 2026 revenue outlook.

Eli Lilly (LLY) and Hims & Hers Health (HIMS) said they signed an agreement to expand patient access to Eli Lilly's weight loss medicines Zepbound and Foundayo. Hims & Hers Health stock was up more than 7% pre-bell.

Humana (HUM) was down 0.6% after the company reported that it swung to a Q3 adjusted loss.